Richard Heyman, Ph.D.

Richard Heyman, Ph.D.

Chair of the BoardatOric Pharmaceuticals· In proxies 2023–2025

Richard Heyman, Ph.D. sits on 10 public boards.

Experience

  1. Oric PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +71%
  2. Alterome Therapeutics, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Pelage PharmaceuticalsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  4. Architect Therapeutics LLCPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  5. Enliven TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  6. PMV PharmaPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  7. CureboundPublic company
    • Director? – PresentNo stock prices for these years
  8. RayzeBio, Inc.Public company · 2 yr
    • Director2022 – 2024 · 2 yrNo stock prices for these years
  9. Gritstone BioPublic company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  10. Yumanity Therapeutics, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  11. Amunix Pharmaceuticals Inc.Public company · 2 yr
    • Director2019 – 2021 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?